Jaipur, Dec 29(KNS): Renowned dermatologist Dr Mir Shahnawaz Bashir, Founder and Director of DERMIS – Skin, Laser and Hair Transplant Clinic, Bemina in Srinagar, was invited as a distinguished speaker at a scientific symposium in Jaipur that focused on Upadacitinib, a new treatment molecule for immune-mediated inflammatory diseases.

The symposium, held on Sunday, brought together dermatologists and rheumatologists from Jaipur, reflecting the growing emphasis on interdisciplinary approaches in the management of complex inflammatory disorders.

During his address, Dr Bashir presented clinical evidence and real-world data on the use of Upadacitinib, outlining its role in improving outcomes for patients with psoriasis, vitiligo, alopecia areata and atopic dermatitis.

He discussed the limitations of conventional therapies and highlighted how targeted immunomodulation is emerging as an effective option in chronic inflammatory skin conditions.

Several senior doctors, including Dr Dinesh Mathur, Dr Deepak Mathur, Dr Manisha Nijhawan and Dr Banwari Sharma, attended the conclave, adding academic depth to the discussions.Click Here To Follow Our WhatsApp Channel

Addressing the gathering, Dr Bashir said that Upadacitinib marked an important advancement in dermatology by enabling faster disease control and improved quality of life for patients with long-standing inflammatory skin disorders.

Participants appreciated the lecture for its scientific clarity and practical relevance, officials associated with the event said.

Dr Bashir’s invitation as a speaker reflects his growing recognition at the national level in the field of dermatology and advanced clinical therapeutics.
His participation was also seen as a significant moment for the medical fraternity in Jammu and Kashmir, highlighting the contribution of specialists from the region to national academic and clinical discourse.(KNS).